MedPath

Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

Phase 4
Terminated
Conditions
Atrial Fibrillation
Medication Adherence
Registration Number
NCT01513031
Lead Sponsor
Creighton University
Brief Summary

The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Prescribed a new anti-arrhythmic medication for atrial fibrillation
Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Adherence to anti-arrhythmic medication1 year

Assessing whether patients stop taking anti-arrhythmic medication without instruction to do so by their physician.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Bryan LGH

πŸ‡ΊπŸ‡Έ

Lincoln, Nebraska, United States

Alegent Health Bergan Mercy Medical Center

πŸ‡ΊπŸ‡Έ

Omaha, Nebraska, United States

Creighton University

πŸ‡ΊπŸ‡Έ

Omaha, Nebraska, United States

Bryan LGH
πŸ‡ΊπŸ‡ΈLincoln, Nebraska, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.